Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03PLR
|
|||
| Former ID |
DIB013136
|
|||
| Drug Name |
RemuneX
|
|||
| Indication | Human immunodeficiency virus-1 infection [ICD-11: 1C62; ICD-10: B20-B24] | Phase 3 | [1], [2] | |
| Melanoma [ICD-11: 2C30; ICD-9: 172] | Discontinued in Phase 3 | [3] | ||
| Company |
Immune response biopharma
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019204) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.